Alivus Life Sciences Board Meeting on July 30, 2026 for Unaudited Results

Alivus Life Sciences Ltd has announced that its Board of Directors will convene on July 30, 2026. The primary agenda item is to consider and approve the company's unaudited financial results for the quarter ended June 30, 2026. In line with SEBI regulations on insider trading, the company has also informed designated persons about the closure of the trading window from July 1, 2026, to August 1, 2026, inclusive, to prevent potential misuse of unpublished price-sensitive information.